Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

New Investigator Grants to Conduct Research to Prevent Interpersonal Violence and Suicide Among Children and Adolescents (K01)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The CDC’s National Center for Injury Prevention and Control is offering a mentored research scientist development award (K01) to foster the growth of new investigators in the field of violence and suicide prevention among children and adolescents aged birth through 17. This award is designed to provide intensive, supervised career development that leads to research independence, ensuring a robust pipeline of scientists equipped to tackle critical public health challenges related to adverse childhood experiences, child abuse and neglect, youth and teen dating violence, sexual violence, and suicide prevention. Applicants must align their proposed research with one or more of the NCIPC’s established priorities and are strongly encouraged to explore intersections among multiple forms of violence or suicide, the impact of technology—including social media—on these issues, and the actionable relevance of their findings to real-world prevention and intervention strategies. The funding opportunity is open to new investigators seeking to build sustained, independent research careers in this domain, with the ultimate goal of advancing evidence-based approaches to reduce harm among youth. The application must clearly identify which NCIPC research priorities are being addressed and should emphasize practical outcomes that can inform policy or clinical practice. While no set-aside or NAICS code is specified, the opportunity is administered through the Department of Health and Human Services and is publicly listed with a point of contact for inquiries, Tamara N. Crawford, whose email is provided for prospective applicants seeking clarification or guidance. The forecasted posting date is July 2, 2026, indicating anticipated availability for submission in the coming years.

General Info

K01 award supports new investigators in youth violence and suicide prevention research aligned with CDC priorities.

Agency

Department Of Health And Human Services → Centers For Disease Control And PreventionView Agency

NAICS

923120 - Administration of Public Health ProgramsView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Centers For Disease Control And Prevention
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Health And Human Services → Centers For Disease Control And Prevention
View Agency Profile
Office AddressUSA
Contacts
Tamara N. Crawford

Full Description

Show more

This Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC) Mentored Research Scientist Development Award (K01) supports an intensive, supervised (mentored) career development experience in violence and suicide prevention research leading to research independence. NCIPC supports K01 grants to help ensure the availability of an adequate number of trained scientists to address critical public health research questions to prevent violence, suicide, and injury.

Applicants must propose a research project that addresses at least one of the research priorities in the NCIPC Research Focus Areas (https://www.cdc.gov/injury-violence-prevention/programs/research-priorities.html) as they relate to violence and suicide impacting children and adolescents (from birth through age 17). These research priorities include: Adverse Childhood Experiences; Child abuse and neglect; Youth violence; Intimate partner violence (teen dating violence); Sexual violence; and Suicide prevention.

Applicants are encouraged to address: (1) Multiple forms of violence, suicide, or both among children and adolescents; (2) The role of technology, such as social media, on interpersonal violence, suicide, or both; and (3) The practical relevance of the research for prevention and intervention efforts. Applicants should explicitly state the NCIPC research priorities their application addresses.

Similar Contracts

Same NAICS industry code

NAICS: 923120
New
Grant
Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India
Solicitation # CDC-RFA-JG-26-0142
Solicitation CDC-RFA-JG-26-0142, titled Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India, is a federal opportunity issued by the Centers for Disease Control and Prevention. The program aims to support India's National AIDS Control Organization, Central Tuberculosis Division, and the Ministry of Health and Family Welfare to enhance systems for epidemic control in alignment with the National AIDS Control Program-VI and the National TB Elimination Program. With an approximate total fiscal year funding of 6,000,000 dollars for Year 1, the initiative focuses on transitioning essential services to local ownership and implementing evidence-based strategies to prevent new infections, facilitate early case detection, and ensure treatment adherence and viral suppression. Key activities under this solicitation include closing gaps in testing and treatment, delivering integrated services for HIV and co-morbidities, and strengthening national program cooperation. By advancing innovative service delivery under local leadership, the project seeks to create a sustainable framework for epidemic control that aligns with U.S. global health priorities to bolster global health security. Interested parties must submit their responses by the deadline of September 16, 2026.
Centers For Disease Control-Ghc

POSTED

about 18 hours ago

DEADLINE

in 29 days
View Details
NAICS: 923120
New
SLED
Enhancement and Expansion of ED-MOUD and Overdose Education and Naloxone Distribution Programs with Outcomes Analysis
Solicitation # 2026-RFA-203
The Mississippi State Department of Health, under the CDC Overdose Data to Action in States Cooperative Agreement, is seeking a subgrantee to enhance and expand Emergency Department-based Medication for Opioid Use Disorder and Overdose Education and Naloxone Distribution programs. This initiative aims to reduce opioid-related morbidity and mortality by improving clinical workflows, expanding access to evidence-based treatment initiation, and strengthening referral pathways and warm-handoff processes to specialty psychiatry and behavioral health services. The project emphasizes the integration of overdose prevention and patient navigation to ensure continuity of care following emergency department encounters. A critical component of the contract is an outcomes-focused analysis to evaluate program effectiveness, patient engagement, and naloxone utilization. This data-driven approach will identify implementation challenges and strategies for sustainability and expansion. The project requires strict adherence to CDC reporting timelines for morbidity and mortality surveillance, including the submission of data via the DOSE and SUDORS systems through May 2028. This solicitation, numbered 2026-RFA-203, was posted on August 14, 2026, with a response deadline of August 28, 2026, and will be performed within the state of Mississippi.
Pharmacy

POSTED

3 days ago

DEADLINE

in 11 days
View Details
NAICS: 923120
New
Grant
Advancing Global Health
Solicitation # DFOP0017890
The Department of State, through the Bureau of Global Health Security and Diplomacy, has issued Annual Program Statement DFOP0017890 to advance the America First Global Health Strategy. This supplemental framework seeks projects that save lives, strengthen health systems, and enhance efficiency to ensure U.S. investments benefit American safety and prosperity. The program focuses on several key areas, including child protection and development for ages 0 to 17, global health security through rapid outbreak detection and containment, and the advancement of integrated health systems, specifically within the Philippines. Total estimated funding is up to 4.5 billion dollars, with the potential for up to 100 awards ranging from a minimum of 500,000 dollars to a maximum of 250 million dollars. Applicants must submit a Statement of Interest (SOI) via grants.gov or MyGrants, adhering to a strict five-page narrative limit and specific formatting requirements. Evaluation is based on a multi-step process including technical eligibility and risk reviews, with equal weighting placed on the quality of the program idea and the organization's capacity and previous grant record. Proposed projects must be completed within one to five years. Key compliance requirements include maintaining an active SAM.gov registration and UEI for phase two proposals, adhering to 2 CFR 200 cost principles, and providing certifications regarding anti-discrimination laws and trafficking in persons for awards exceeding 500,000 dollars performed outside the United States.
Bureau Of Global Health Security And Diplomacy

POSTED

4 days ago

DEADLINE

in 6 months
View Details

More opportunities from Department Of Health And Human Services → Centers For Disease Control And Prevention

Same awarding agency

NAICS: 541715
Grant
Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE NetworkThe Centers for Disease Control and Prevention is seeking applicants to sustain and expand the US Influenza Vaccine Effectiveness Network, which aims to generate critical data on the effectiveness of influenza and other respiratory pathogen vaccines across all age groups. The initiative requires proposing work under four interconnected components: annual vaccine effectiveness and correlates of protection surveillance through active outpatient enrollment and systematic pathogen testing; electronic surveillance for acute respiratory illness and vaccine effectiveness; household transmission research; and immunogenicity studies. Applicants must apply for either Component A or Component B, but not both, with the option to add Component C or D as supplementary proposals. Component A focuses on direct surveillance and is anticipated to fund up to five sites at $1,800,000 annually, while Component B supports coordination and surge capacity with one site funded at the same level. Optional Component C, focused on household transmission, may be awarded to up to two Component A sites at $100,000 annually, and optional Component D for immunogenicity research may be granted to up to three sites from either Component A or B at $750,000 annually. The opportunity is open through a forecasted notice issued by the Department of Health and Human Services, with point of contact information provided for inquiries.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

21 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Expanded Surveillance for Pediatric Infectious DiseasesThe Centers for Disease Control and Prevention is seeking to establish a network of U.S. institutions to conduct standardized, prospective surveillance of pediatric acute respiratory illness and acute gastroenteritis, with a focus on identifying and characterizing respiratory and enteric viruses among children seeking medical care. The core requirement involves active surveillance in inpatient and emergency department settings, following CDC-established protocols to enroll patients based on standardized symptom criteria and confirm viral infections using approved molecular assays. This foundational component will generate critical data on hospitalization rates, disease progression, and the effectiveness of prevention tools such as vaccines for influenza, rotavirus, and respiratory syncytial virus. Optional components allow recipients to extend surveillance to outpatient clinics and conduct supplementary research on immune response to infection and immunization, enhancing the depth of biological and epidemiological insights. The network’s findings are intended to directly inform public health policy, improve diagnostic and treatment guidelines, and shape recommendations for prevention products to reduce the burden of viral illness in children. Outcomes will support evidence-based strategies to lower healthcare utilization and hospitalizations among pediatric populations. Applications must include the core component, with the option to add one or more supplementary components to expand scope. The opportunity is posted under the title Expanded Surveillance for Pediatric Infectious Diseases, classified under NAICS code 541715, with point of contact available through the CDC for procedural inquiries. The funding opportunity is forecasted for release in July 2026, targeting institutions capable of sustained, high-quality clinical data collection and analysis in alignment with national public health priorities.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

21 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Health Promotion and Disease Prevention Research Centers: 2027 Special Interest Project Supplements (SIPS)The Centers for Disease Control and Prevention, under the Department of Health and Human Services, is offering supplemental funding to its twenty existing Prevention Research Centers to support Special Interest Projects aimed at advancing public health practice through applied research in real-world settings. These projects are designed to identify, test, evaluate, and translate evidence-based interventions that prevent and reduce the leading causes of illness, disability, and death in the United States. The funding will enable the centers to carry out ten targeted initiatives focusing on areas such as cancer survivorship care planning, leveraging Medicare and cancer registry data to improve clinical care and trial enrollment, developing community-based messaging to reduce alcohol use for cancer prevention, enhancing access to gynecologic oncologists for ovarian cancer patients, creating visual tools for sunscreen application, building emergency preparedness plans linked to weather events, establishing frameworks for prostate cancer care and support services, advancing public health strategies for hereditary cancer, and exploring emerging issues in chronic disease prevention and care. Applications are open to the current network of CDC Prevention Research Centers, with no set-aside or specific eligibility criteria beyond existing funding status. The opportunity was posted on July 28, 2026, and inquiries should be directed to Natalie Darling, MPH, Scientific Program Official, at researchnofo@cdc.gov or 770-488-5740. The projects are expected to produce actionable findings that inform policy, improve clinical and community-based practices, and ultimately contribute to reducing the burden of preventable diseases across the nation. No NAICS code or place of performance is specified, indicating that work may be conducted across the centers’ existing geographic and institutional networks.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

21 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
NIOSH Exploratory/Developmental Grant Program (R21)The NIOSH Exploratory/Developmental Grant Program (R21) aims to drive advancements in occupational safety and health by supporting innovative research that identifies workplace hazards, develops effective risk reduction strategies, and translates scientific discoveries into practical prevention tools and products. The program prioritizes projects that introduce novel scientific concepts, new model systems, or transformative technologies with the potential to significantly reduce work-related illnesses and injuries. Applicants are expected to clearly define the occupational health burden their research addresses, articulate how their proposed activities will generate tangible outputs to alleviate this burden, and outline both immediate and long-term impacts of their work. This funding opportunity is managed by the Centers for Disease Control and Prevention under the Department of Health and Human Services, with scientific oversight provided by NIOSH. The NAICS code 541715 indicates the focus on research and development in the physical, engineering, and life sciences. The solicitation is forecasted for posting on July 27, 2026, and interested parties can direct inquiries to Bridgette Garrett, PhD, the designated Scientific Program Official, via email at bgarrett@cdc.gov or phone at 770-488-5715. The opportunity is open to domestic applicants, with no set-aside designation specified, and all performance activities are expected to take place within the United States.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

22 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Pilot Testing, Implementation, and Evaluation of the Cervical, Breast and Colorectal Cancer Clinical Decision Support ToolsThe Centers for Disease Control and Prevention is seeking proposals to pilot test, implement, and evaluate clinical decision support tools for cervical, breast, and colorectal cancer screening and management. The initiative targets large health systems and aims to integrate computable, evidence-based guidelines directly into electronic health record systems to improve clinician decision-making at the point of care. Component A focuses on full-scale implementation and rigorous evaluation of an existing cervical cancer CDS tool, with emphasis on increasing guideline-concordant screening and ensuring timely follow-up after abnormal results. Component B involves the technical integration and empirical evaluation of interoperable CDS tools for breast and colorectal cancer, requiring documentation of the implementation process and measurement of tool accuracy and real-world impact. Both components build on previously developed CDC algorithms and require applicants to demonstrate robust assessment methods for effectiveness and adoption within operational healthcare environments. Proposals must align with CDC’s goal of advancing equitable, data-driven cancer prevention strategies across diverse clinical settings.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

25 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
NIOSH Small Research Grant Program (R03)The NIOSH Small Research Grant Program (R03) is designed to advance occupational safety and health by supporting research that identifies risks and conditions leading to work-related diseases and injuries, explores strategies to reduce those risks, and translates scientific discoveries into practical prevention tools and practices. This grant mechanism is intended for projects that can be completed with limited resources, such as pilot studies, feasibility assessments, secondary data analysis, or the development of new research methodologies, making it accessible for early-stage or resource-constrained investigators. Applicants are required to clearly define the occupational health problem they aim to address and explicitly connect their proposed activities to measurable outputs that will reduce the burden of work-related illness and injury, both during the grant period and in the long term. Funded by the Centers for Disease Control and Prevention under the Department of Health and Human Services, the program is open to researchers seeking to generate actionable insights that can inform workplace safety practices. The solicitation is currently forecasted for a July 2026 posting, with no set-aside type or NAICS code specified. The point of contact for inquiries is Jessica M.K. Streit, PhD, CHES, Scientific Program Official, reachable via email at jstreit@cdc.gov or phone at 513-533-8107. While the place of performance and organization type are not defined, the grant supports research activities that must be grounded in real-world occupational health challenges and must demonstrate potential for tangible impact beyond the academic setting.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

26 days ago

DEADLINE

N/A
View Details
NAICS: 561920
Grant
NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)The NIOSH Support for Conferences and Scientific Meetings (U13) program is designed to fund high-quality scientific gatherings that advance occupational safety and health research in alignment with NIOSH’s strategic priorities. These events may include conferences, symposia, workshops, or seminars, whether held in person or virtually, and must focus on exchanging knowledge, coordinating efforts, or clarifying key issues in the field. The program explicitly excludes training-only events and requires that proposed meetings contribute meaningfully to research objectives central to NIOSH’s mission. This cooperative agreement mechanism allows for substantial federal involvement, with NIOSH staff potentially assisting in planning, coordinating, and participating in activities before and after the award. The opportunity is posted under the Centers for Disease Control and Prevention, part of the Department of Health and Human Services, with no set-aside or NAICS code specified. Prospective applicants can direct inquiries to Sharon Chiou, PhD, the Scientific Program Official, via email or phone. The forecast dates to July 22, 2026, indicating an anticipated release timeline for formal applications, though the solicitation number is not yet available. The place of performance is not restricted to a specific location, allowing for flexibility in meeting venues, and all proposed activities must remain within the scope of public health research relevant to worker safety and health.
Convention and Trade Show Organizers

POSTED

27 days ago

DEADLINE

N/A
View Details